- Home
- LAKE vs LYEL Comparison
LAKE vs LYEL Comparison
Compare LAKE & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAKE
- LYEL
- Stock Information
- Founded
- LAKE 1982
- LYEL 2018
- Country
- LAKE United States
- LYEL United States
- Employees
- LAKE N/A
- LYEL N/A
- Industry
- LAKE Industrial Specialties
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- LAKE Health Care
- LYEL Health Care
- Exchange
- LAKE Nasdaq
- LYEL Nasdaq
- Market Cap
- LAKE 180.8M
- LYEL 207.7M
- IPO Year
- LAKE 1986
- LYEL 2021
- Fundamental
- Price
- LAKE $13.66
- LYEL $9.20
- Analyst Decision
- LAKE Strong Buy
- LYEL Sell
- Analyst Count
- LAKE 3
- LYEL 2
- Target Price
- LAKE $26.00
- LYEL $15.00
- AVG Volume (30 Days)
- LAKE 301.0K
- LYEL 140.3K
- Earning Date
- LAKE 09-03-2025
- LYEL 08-06-2025
- Dividend Yield
- LAKE 0.88%
- LYEL N/A
- EPS Growth
- LAKE N/A
- LYEL N/A
- EPS
- LAKE N/A
- LYEL N/A
- Revenue
- LAKE $177,648,000.00
- LYEL $65,000.00
- Revenue This Year
- LAKE $32.98
- LYEL N/A
- Revenue Next Year
- LAKE $4.70
- LYEL N/A
- P/E Ratio
- LAKE N/A
- LYEL N/A
- Revenue Growth
- LAKE 34.28
- LYEL N/A
- 52 Week Low
- LAKE $12.76
- LYEL $7.65
- 52 Week High
- LAKE $27.28
- LYEL $38.40
- Technical
- Relative Strength Index (RSI)
- LAKE 40.63
- LYEL 51.18
- Support Level
- LAKE $13.38
- LYEL $9.58
- Resistance Level
- LAKE $14.45
- LYEL $10.41
- Average True Range (ATR)
- LAKE 0.55
- LYEL 0.55
- MACD
- LAKE 0.18
- LYEL 0.03
- Stochastic Oscillator
- LAKE 44.57
- LYEL 61.54
About LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.